Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A sign of vaccine maker Changsheng Bio-technology Co Ltd is pictured at its building in Changchun, Jilin, China July ...

Add Yahoo as a preferred source to see more of our stories on Google. A box of vials containing the rabies vaccine manufactured by the vaccine maker Changsheng Biotechnology, is seen next to a sealed ...

Mainland China vaccines producer Changsheng Bio-Technology, which was fined 9.1 billion yuan (US$1.3 billion) for falsifying data and selling ineffective vaccines in July, has become the first company ...

Changsheng Wu (53), has been appointed Executive Vice President, Procurement and member of the Global Executive Team at Huhtamaki, effective April 1, 2025. He will report to President and CEO Ralf K.

SHANGHAI (Reuters) - Chinese vaccine maker Changsheng Bio-technology Co Ltd, accused of fabricating production and inspection data, has become the subject of multiple probes - including investigations ...

Having lost half its market value in the space of seven days after regulators found it had fabricated data for its rabies vaccines, Chinese pharmaceuticals maker Changsheng Bio-technology now faces a ...

SHANGHAI (Reuters) - Changsheng Bio-technology Co Ltd, a vaccine maker at the centre of a safety scandal in China, began falsifying production records for its rabies vaccine in April 2014, state news ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Talk about swallowing a bitter pill. Changsheng Biotechnology, the drugmaker at the centre of China’s latest ...

BEIJING (Reuters) - A unit of China's vaccine maker Changsheng Bio-technology Co Ltd has been hit with penalties totaling 9.1 billion yuan ($1.32 billion) after it was embroiled in a scandal over ...